PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Pharmaceutical and Medicinal Chemistry (PharMedChem), Federal University of Amapá, Macapá, Amapá, Brazil. Electronic address: lorane@unifap.br.\', \'Computational Laboratory of Pharmaceutical Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.\', \'Laboratory of Pharmaceutical and Medicinal Chemistry (PharMedChem), Federal University of Amapá, Macapá, Amapá, Brazil.\', \'Computational Laboratory of Pharmaceutical Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Department of Chemistry, School of Philosophy, Sciences and Letters of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0024-3205(20)30713-X10.1016/j.lfs.2020.117963
?:hasPublicationType
?:journal
  • Life sciences
is ?:pmid of
?:pmid
?:pmid
  • 32535080
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.071
?:rankingScore_hIndex
  • 145
?:title
  • Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all